R3 Stem Cell and Founder Dr. David Greene have been featured in the Cover story for 10 Best Healthcare Companies to Watch in 2022 by Silicon Review Magazine. After a decade of providing first-rate regenerative therapies, R3 has become the global leader for patients desiring safe, effective procedures for over 50 different conditions. With 45 centers in six countries, over 20,000 regenerative therapies have been performed for many different conditions.
“I appreciate the honor, and my goal is to continue growing so we can help more patients improve their quality of lives! Our treatments are the most cost-effective in the world!”
R3’s treatments are available in six countries, with biologics that are not only first-rate, safe, and include high stem cell counts, but the treatments are the most cost-effective worldwide.
The combination of quality, safety, and cost-effectiveness has propelled R3 Stem Cell to be the worldwide leader for patients desiring the best option for treatment. “Patients end up realizing that while regenerative therapies are not a cure, they are typically extremely beneficial.
But they will need to be repeated, so we have used our volume buying power to bring the cost of these procedures way down! That way, a repeat procedure is within reach of patients and their families.”
R3 Medical Training was created five years ago to offer CME accredited training courses on regenerative therapies for providers desiring an education in the new technology.
The stem cell training course includes two days of didactic and hands-on training for providers to gain significant skill sets for incorporating into practice. In addition, R3 offers medical aesthetics training that incorporates PRP, exosomes, fillers, and neurotoxins as well.
As a Healthcare Company to Watch, R3 is at the forefront of regenerative medicine. Over the next year, R3 Medical Research is starting four clinical trials internationally. In addition, R3 will be opening in several new countries over the next year. Added Dr. Greene, “I appreciate the honor, and my goal is to continue growing so we can help more patients improve their quality of lives!”
Dr. David Greene
MD, PhD, MBA
Dr. David Greene, MD, PhD, MBA, is a pioneering leader in regenerative medicine and healthcare marketing. As a residency and fellowship-trained orthopedic surgeon, Dr. Greene transitioned from clinical practice to become the founder and CEO of R3 Stem Cell and US Lead Network, where he has revolutionized patient care and medical practice growth through innovative therapies and digital marketing strategies. He has authored two influential books on healthcare internet marketing, ranks among the top expert authors globally, and has been featured on the cover of Corporate Vision magazine for his impact on global regenerative therapies. Beyond his professional achievements, Dr. Greene is passionate about education, compassion, and continuous innovation.
Sorry, the comment form is closed at this time.